Of interest, increased serum levels of ApoA‐IV were previously reported in patients with allergic rhinitis under allergen‐specific immunotherapy.28 We made the surprising observation that ApoA‐IV serum levels are noticeably reduced in therapy‐naïve allergic patients. Here, APOA4 is linked to allergic rhinitis.